Inspire Medical Systems Retained Earnings (Accumulated Deficit) 2017-2024 | INSP
Inspire Medical Systems retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Inspire Medical Systems retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-0.327B, a 9.18% decline year-over-year.
- Inspire Medical Systems retained earnings (accumulated deficit) for 2023 were $-0.345B, a 6.52% increase from 2022.
- Inspire Medical Systems retained earnings (accumulated deficit) for 2022 were $-0.324B, a 16.06% increase from 2021.
- Inspire Medical Systems retained earnings (accumulated deficit) for 2021 were $-0.279B, a 17.71% increase from 2020.
| Inspire Medical Systems Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-345 |
| 2022 | $-324 |
| 2021 | $-279 |
| 2020 | $-237 |
| 2019 | $-180 |
| 2018 | $-147 |
| 2017 | $-125 |
| 2016 | $ |
| Inspire Medical Systems Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-327 |
| 2024-06-30 | $-346 |
| 2024-03-31 | $-355 |
| 2023-12-31 | $-345 |
| 2023-09-30 | $-360 |
| 2023-06-30 | $-352 |
| 2023-03-31 | $-340 |
| 2022-12-31 | $-324 |
| 2022-09-30 | $-327 |
| 2022-06-30 | $-311 |
| 2022-03-31 | $-296 |
| 2021-12-31 | $-279 |
| 2021-09-30 | $-277 |
| 2021-06-30 | $-267 |
| 2021-03-31 | $-254 |
| 2020-12-31 | $-237 |
| 2020-09-30 | $-230 |
| 2020-06-30 | $-219 |
| 2020-03-31 | $-196 |
| 2019-12-31 | $-180 |
| 2019-09-30 | $-171 |
| 2019-06-30 | $-163 |
| 2019-03-31 | $-155 |
| 2018-12-31 | $-147 |
| 2018-09-30 | $-142 |
| 2018-06-30 | $-137 |
| 2018-03-31 | $-132 |
| 2017-12-31 | $-125 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.430B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
| Tempus AI (TEM) | United States | $10.232B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
| IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
| Privia Health (PRVA) | United States | $2.723B | 226.90 |
| Enovis (ENOV) | United States | $2.544B | 16.95 |
| Azenta (AZTA) | United States | $2.469B | 114.98 |
| Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
| Schrodinger (SDGR) | United States | $1.886B | 0.00 |
| Omnicell (OMCL) | United States | $1.826B | 39.83 |
| 10x Genomics (TXG) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.680B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
| Talkspace (TALK) | United States | $0.608B | 0.00 |
| Standard BioTools (LAB) | United States | $0.529B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| TruBridge (TBRG) | United States | $0.380B | 110.57 |
| Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| American Well (AMWL) | United States | $0.176B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
| CareCloud (CCLD) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |